Neo-Quipenyl en es it fr

Neo-Quipenyl Brand names, Neo-Quipenyl Analogs

Neo-Quipenyl Brand Names Mixture

  • No information avaliable

Neo-Quipenyl Chemical_Formula


Neo-Quipenyl RX_link

No information avaliable

Neo-Quipenyl fda sheet

Neo-Quipenyl FDA

Neo-Quipenyl msds (material safety sheet)

Neo-Quipenyl Synthesis Reference

No information avaliable

Neo-Quipenyl Molecular Weight

259.347 g/mol

Neo-Quipenyl Melting Point

< 25 oC

Neo-Quipenyl H2O Solubility

No information avaliable

Neo-Quipenyl State


Neo-Quipenyl LogP


Neo-Quipenyl Dosage Forms


Neo-Quipenyl Indication

For the treatment of malaria.

Neo-Quipenyl Pharmacology

Primaquine is an antimalarial agent and is the essential co-drug with chloroquine in treating all cases of malaria. In the blood, malaria parasites break down a part of the red blood cells known as haemoglobin. When this happens haemoglobin is divided into two parts; haem and globin. Haem is toxic to the malaria parasite. To prevent it from being damaged, the malaria parasite produces an chemical which converts the toxic haem into a non-toxic product. Primaquine acts by interfering with a part of the parasite (mitochondria) that is responsible for supplying it with energy. Without energy the parasite dies. This stops the infection from continuing and allows the person to recover. Primaquine kills the intrahepatic form of Plasmodium vivax and Plasmodium ovale, and thereby prevents the development of the erythrocytic forms that are responsible for relapses (it also kills gametocytes). Primaquine is not used in the prevention of malaria, only in the treatment. It has insignificant activity against the asexual blood forms of the parasite and therefore it is always used in conjunction with a blood schizonticide and never as a single agent. Primaquine has gametocytocidal activity against all plasmodia, including P. falciparum.

Neo-Quipenyl Absorption

No information avaliable

Neo-Quipenyl side effects and Toxicity

No information avaliable

Neo-Quipenyl Patient Information

No information avaliable

Neo-Quipenyl Organisms Affected